“amyotrophic-lateral-sclerosis” Archives

in
Entry Author Date Location
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech 10/25/18 Texas
New Biotech Magnolia Neurosciences Gets $31M For Neuroprotective Drugs 08/13/18 New York
Verge Genomics Nabs $32M For Computation-Heavy Neuro Drug Discovery 07/16/18 San Francisco
Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs 04/20/18 Boston
Patient Network Group Says Majority of Members Want To Keep Obamacare 06/14/17 Boston
Royalty Pharma Pays $90M to Cytokinetics for Heart Drug Royalties 02/02/17 San Francisco
Amylyx Nabs $5M to Take Aim at Nerve Cell Death in ALS Patients 08/22/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
Cytokinetics Gets $95M in First ALS Deal, Needs Results For More 07/27/16 San Francisco
Sharpening Neuro Focus, Biogen to Spin Out Hemophilia Biz 05/03/16 Boston
One Year Post-Launch, Yumanity Lands $45M For Yeasty Discovery 02/10/16 Boston
Amid Spotlight On Concussions, New Efforts To Improve Gear, Tackling 12/29/15 Wisconsin
NY Stem Cell Foundation Grows, Eyes Forming Big Apple Bio Incubator 12/03/15 New York
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
Speech Startup VocaliD Creates Personalized Voices With Crowd’s Help 06/15/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M 09/09/14 Boston
East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More 09/05/14 Boston
Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager 09/03/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
Page 1 of 2 next page »